HIV

The AJMC® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.

Latest News

Domestic violence | Image credit: vectorfusionart - stock.adobe.com
Women Experiencing Partner Violence More Motivated to Receive PrEP

November 25th 2024

Women with higher symptoms of post-traumatic stress disorder and major depressive disorder after intimate partner violence were more likely to have higher motivation to receive pre-exposure prophylaxis (PrEP).

Vaccination | Image credit: Prostock-studio - stock.adobe.com
HPV Vaccination Cost-Effective at Preventing Cervical Cancer in Patients With HIV

November 21st 2024

HIV | Image credit: Corona Borealis - stock.adobe.com
New Data Provide Clearer Picture on Adherence to Lenacapavir

November 18th 2024

HIV | Image credit: RAJCREATIONZS - stock.adobe.com
BIC/FTC/TAF Effective at Virologic Suppression in HIV Presenting Late

November 15th 2024

Liver | Image credit: PIC4U - stock.adobe.com
Liver Steatosis, Fibrosis Highly Prevalent in People Living With HIV

November 12th 2024

Clarifying USPSTF Recommendations for HIV Pre-Exposure Prophylaxis (PrEP)

This discussion focuses on how to address barriers and disparities as obstacles to using PrEP, with a focus on USPSTF PrEP guidelines and ACA Part 47 for payers and providers.

This multi-stakeholder roundtable panel discussion will focus on how to address barriers and disparities as obstacles to the use of PrEP, with a focus on increased understanding and education around US Preventive Services Task Force (USPSTF) PrEP guidelines and Affordable Care Act Part 47 for payers and providers.

More News

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo